Pfizer says Sutent fails in breast cancer studies MiamiHerald.com Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies Huffington Post (blog) Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
The Bald Women Trend - Would You Ever? StyleList (blog) He adds, "For women who are losing hair due to chemotherapy, shaving the head can be a bold, beautiful statement. For most people, though, I'd strongly ...
Pfizer says Sutent fails in breast cancer studies San Luis Obispo Tribune Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies York Daily Record Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Stocks in focus for Friday MarketWatch ... drug Sutent failed to show a significant benefit to advanced breast cancer patients when used with chemotherapy compared with using chemotherapy alone. ...
Pfizer says Sutent fails in breast cancer studies San Francisco Chronicle Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies phillyBurbs.com Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies KAALtv.com Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies Seattle Times Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer ends study on potential lung cancer drug San Diego Union Tribune By AP NEW YORK Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, ...
Pfizer says Sutent fails in breast cancer studies Hilton Head Island Packet Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
